| Returns | 1W : -1% , 1M : 9.2%,1Y : 51.4% |
| Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC PHARMACEUTICALS | -1% | 9.2% | 51.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.4% | 6.7% | 41% |
| DR REDDYS LABORATORIES | 2.8% | 12.7% | 27.3% |
| DIVIS LABORATORIES | 1.9% | 12.1% | 58.1% |
| CIPLA | 6.4% | 16.6% | 54.3% |
| BIOCON | -1.8% | 4.3% | 20.1% |
| AUROBINDO PHARMA | 1% | 14.2% | 77.7% |
| LUPIN | -2.2% | -0.5% | 29.5% |
| TORRENT PHARMACEUTICALS | 1.8% | 7.7% | 11.6% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
22.76
P/E Calculated based on EPS of 43.97
[ Mar2020 - Consolidated Results ] 5.86
P/B Calculated based on Book Value of 170.79
[ Mar2020 - Consolidated Results ] 3.77
P/S Calculated based on Revenues of 5214.38 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
16% 21% 22% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 1.2% | 9.2% | 53% |
| S&P BSE 200 | -1.7% | -1.6% | 65.2% |
| S&P BSE 250 LARGEMIDCAP | -1.7% | -1.6% | 65.5% |
| S&P BSE 500 | -1.8% | -1.7% | 67.2% |
| S&P BSE ALLCAP | -1.9% | -1.7% | 68.2% |
| S&P BSE SMALLCAP SELECT INDEX | -1.9% | 1.1% | 93.1% |
| S&P BSE 150 MIDCAP | -2.7% | -0.7% | 85.9% |
| S&P BSE SMALL CAP | -2.7% | -0.4% | 100.6% |
| S&P BSE MIDSMALLCAP | -2.8% | -0.8% | 87.9% |
| S&P BSE 400 MIDSMALLCAP | -2.9% | -1.3% | 90% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 200 | -1.7% | -1.7% | 64.1% |
| NIFTY 500 | -1.8% | -1.7% | 66.6% |
| NIFTY LARGE MIDCAP 250 | -2.2% | -1.4% | 73.1% |
| NIFTY MIDCAP150 | -2.8% | -1.1% | 85.4% |
| NIFTY MID SMALL400 | -3% | -1.4% | 90.5% |
| NIFTY FREE MIDCAP 100 | -3% | -0.8% | 87.7% |
